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Abstract Hybridomas producing monoclonal antibodies (mAbs)
against the mistletoe lectin A-chain (MLA) were obtained to
investigate the intracellular routing and translocation of
ribosome-inactivating proteins. Anti-MLA mAb MNA5 did not
bind the holotoxin but interacted with isolated MLA. This
epitope was not recognized upon MLA denaturation or conjuga-
tion of MLA with the ricin binding subunit (RTB). Furthermore,
the mAbs did not appreciably react with a panel of MLA
synthetic octapeptides linked to the surface of polyethylene pins.
A study of the cytotoxicity of mistletoe lectin, ricin, and chimeric
toxin MLA/RTB for the hybridomas revealed that interchain
disulfide bond reduction and subunit dissociation are required for
cytotoxic activity of mistletoe lectin.
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1. Introduction
Mistletoe lectin from Viscum album is a type II ribosome-
inactivating protein (RIP), comprising a toxic A-chain and a
carbohydrate-binding B-chain linked by a disul¢de bond, like
other members of this family including ricin, abrin, and mod-
ecin [1]. These toxic proteins are potent inhibitors of eukary-
otic protein synthesis at the ribosomal level. The A-chain in-
hibits protein synthesis by enzymatic depurination of an
adenosine residue in a highly conserved loop of the 28S ribo-
somal RNA [2]. Since type II RIP are very e⁄cient in target
cell toxicity, they have been used in producing immunotoxins,
pharmaceuticals against tumor and immunocompetent cells to
be applied in autoimmune diseases and transplantology [3].
Endocytosis of the protein is mediated by the lectin B-chain
which has multiple potential sugar binding sites, interacting
with glycosidic residues on the surface of target cells. Follow-
ing endocytosis, the process of intracellular tra⁄cking is not
clear, but recent work implicates the endoplasmic reticulum
(ER) in the toxin translocation [4]. The e⁄cacy of RIP II in
inhibiting mammalian protein synthesis is dependent on the
toxin translation e⁄cacy. In the case of ricin, the B-chain is
believed to mediate the translocation of the A-chain [5]. Un-
like the bacterial toxins, no distinct translocation domain has
been identi¢ed in RIP II. Understanding the mechanism by
which RIP II reaches the cytosol would help in designing
better toxin and immunotoxin molecules with new structural
motifs for improved translocation.
It is not yet clear whether the toxins are translocated as
holomolecules or are reduced and then translocated. There
is evidence for translocation of the holotoxin: (1) a ricin
with a non-dissociating bond between A- and B-chains has
the same cytotoxic activity as the native protein [6] ; (2)
most RIP II holomolecules have enzymatic activity su⁄cient
for inhibition of protein synthesis [2] ; (3) the depth of ricin
permeation into a phospholipid bilayer is almost equal for
holotoxin and the isolated A-chain [7].
Hybridoma cells producing monoclonal antibodies (mAb)
against plant toxins are convenient models for investigating
both the toxin pathway in the mammalian cell and the sig-
ni¢cance of protein epitopes for toxin-mediated cytotoxicity.
We developed a panel of mAbs to mistletoe lectin (ML), and
present evidence for the role of disul¢de bond reduction and
subunit dissociation as an obligate step in toxin translocation
into the cytosol. The anti-MLA mAb MNA5 does not bind
the holotoxin; the interaction of the mAb with the toxin after
reducing treatment and protein heat denaturation is charac-
terized. Our cytotoxic experiments with hybridomas reveal
that the interchain disul¢de bond reduction and dissociation
of the subunits is a prerequisite for cytotoxicity.
2. Materials and methods
2.1. Materials
Cell culture medium RPMI 1640, L-glutamine, kanamycin, and fetal
calf serum were from Flow Labs (Woodcock Hill, UK); protein A-
Sepharose from LKB-Pharmacia (Uppsala, Sweden); 96-well micro-
titer plates from Nunclon (Roskilde, Denmark); streptavidin labelled
with peroxidase and polyclonal rabbit anti-mouse immunoglobulins
from IMTEK (Moscow, Russia); all other reagents were obtained
from Sigma (St. Louis, MO, USA).
2.2. Protein puri¢cation
Mistletoe lectin and its subunits were isolated as previously de-
scribed [8]. The chimeric toxin consisting of MLA and B subunit of
ricin was prepared as previously described [9]. To produce the hybrid-
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omas to MLA, spleen cells from BALB/c mice immunized with MLA
were hybridized with SP2/0 murine myeloma cells. The hybridomas
were tested by ELISA with biotinylated ML and MLA. mAbs from
ascitic £uid were puri¢ed by a⁄nity chromatography on protein A-
Sepharose. Biotinylation was performed with biotinamidocaproate N-
hydroxysuccinimide ester as recommended by Sigma. Protein purity
was estimated with SDS polyacrylamide gel electrophoresis (10%).
2.3. Binding and cytotoxic assays
The interaction of mAbs with mistletoe lectin was analyzed in ELI-
SA; the data were read with a Multiscan spectrophotometer (LabSys-
tems, Finland). Mistletoe lectin cytotoxicity was estimated by cell
survival in the MTT test [10]. IC50 was used to compare the cytotoxic
activity of di¡erent proteins.
2.4. Epitope prediction and peptide synthesis
Epitope prediction was carried out according to [11] using the
DSSP program. The mistletoe lectin and ricin amino acid sequences
were aligned using the FASTA program and Swiss-Prot data base.
Protein fragments each containing eight amino acid residues of MLA
were synthesized as a special application of PEPSCAN (peptide scan-
ning approach) [12]. Peptides were synthesized and attached to poly-
ethylene pins by the active ester coupling procedure using 9-£uorenyl-
methyloxycarbonyl-amino acid-penta£uorophenyl esters in the
presence of an equimolar amount of 1-hydroxybenzotriazole accord-
ing to the manufacturer’s instructions (Cambridge Research Biochem-
icals Co., UK). Interaction of mAbs with the peptides was analyzed
by ELISA.
3. Results and discussion
After screening, we picked out three clones producing anti-
bodies reacting most e¡ectively with isolated native MLA:
MNA4, MNA5 and MNA9.
mAb MNA5, in contrast to the other mAbs, does not in-
teract with native mistletoe lectin, chimeric toxin MLA/RTB
(Fig. 1), or MLA absorbed on a microtiter plate. All other
mAbs react with both native and absorbed forms of ML.
Evidently, MNA5 recognizes a conformational epitope which
is hidden by the B-subunit in the native molecule of ML.
mAbs MNA4 and MNA9 bind the holotoxin and isolated
MLA equally.
To investigate the conditions of MNA5 epitope exposure in
ML, the holotoxin was dissociated by reducing the S-S bond
with dithiothreitol (DTT). This was veri¢ed by sandwich ELI-
SA with mAbs against MLA and mAb TB12 against MLB
(data not shown). DTT elicited the MNA5 epitope after dis-
sociation of the subunits. Denaturation of mistletoe lectin by
heating to 100‡C did not yield an MNA5-reactive epitope.
The endocytosed toxin has been shown to be routed to the
Golgi apparatus via acidic endosomes. The pH 5.5 treatment
of ML in our experiments had no e¡ect on the binding of
MNA5 to the holotoxin (data not shown).
For MNA5 epitope prediction in MLA, we used three-di-
mensional structure analysis of the monomeric and dimeric
protein forms [13]. Amino acids that changed their solvent
accessibility after A-B heterodimer formation were revealed;
these were numbers 18, 35^38, 170^171, 174, 177^178, 191,
210^211, 213, 215, 222, 228^229, 231^232, 234^235, 237^241,
248^252. Then we chose amino acid residues in the regions
with maximum mobility and temperature B-factor and not
included in the secondary structure elements in the X-ray
model [14]. The ¢nal choice included the analysis of amino
acid sequence variability in homologous proteins; non-conser-
vative domains had maximum preference. As a result, the
following possible MNA5 epitopes were proposed: 248^254,
222^229, 210^219 and 174^182. We have investigated the in-
teraction of the mAbs and of polyclonal mouse serum with a
panel of octapeptides of MLA synthesized and linked by their
C-terminal carboxyl group to the surface of polyethylene pins
(Fig. 2). Polypeptides numbered 1^2 include residues 174^182;
nos. 3^6, 196^206; nos. 7^9, 210^219; nos. 10, 222^229; nos.
11^12, 231^239; nos. 13, 248^255. Polyclonal antibodies from
the serum of MLA immunized mice whose spleen cells had
been taken for fusion with SP2/0 cells to produce hybridomas
interacted mainly with two fragments containing residues
231^238 and 232^239 from the MLA sequence (Fig. 2). How-
ever, our mAbs did not bind with the surface-attached MLA
fragments. This demonstrates again that MNA5 cannot inter-
act with denatured (unfolded) MLA fragments.
The cytotoxic activity of mistletoe lectin and ricin against
hybridoma cells producing anti-MLA mAbs is presented in
Fig. 3. The sensitivity of MNA4 and MNA5 hybridoma cells
to ML is 70 times less than that of SP2/0 cells. The IC50 of
chimeric toxin MLA/RTB for MNA5 cells is 40 times higher
than for control SP2/0 cells. The sensitivity of SP2/0 and
TA75 hybridoma cells against denatured MLA to ML is
equal. ELISA shows that no mAb binds ricin and that the
hybridomas have equal sensitivity to this toxin.
The sensitivity of hybridoma cells producing mAbs to ML
Fig. 1. Interaction of mAbs MNA5 (1, 2) and MNA9 (3, 4) with
antigens in sandwich ELISA with biotinylated MNA4. A: MLA (1,
3), ML (2, 4). B: MLA (1, 3), MLA/RTB (2, 4). mAbs at 0.01 mg/
ml PBS were adsorbed for 16 h at 4‡C on microtiter plates, which
were then reacted at 37‡C for 60 min with the antigen and 60 min
with biotinylated Abs (with washing at each step), and developed
with streptavidin-peroxidase.
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depends on the intracellular interaction of mAb with toxin
molecules. Additionally, mAbs in the hybridoma culture me-
dia might prevent ML binding to the cells. We excluded this
binding by repeated washing of cells with cell culture media
without serum. The maximum number of binding sites for
ML on speci¢c and control hybridoma cells does not di¡er
(data not shown). Papain treatment of the cells to eliminate
external mAb molecules does not change the sensitivity to the
toxin [15]. Thus, hybridoma cell resistance is due to intracel-
lular interaction of toxins with newly synthesized antibody
molecules.
The resistance of MNA5 hybridoma cells to ML shows that
mAb molecules bind toxin molecules after reduction of the
disul¢de bond between the A- and B-chains of the toxin
and its dissociation. The reduction could take place in the
ER containing a redox complex, i.e. reduced glutathione
and protein disul¢de isomerase [1]. After the A-chain has
been translocated from the ER lumen, it may utilize, in the
reverse direction, the ER membrane translocation apparatus
normally involved in the co-translational translocation of se-
cretory proteins across the mammalian ER membrane, the
Sec61p complex [16]. No direct evidence for the reverse trans-
location step has yet been obtained. Conceivably, the A-chain
export to the cytosol could utilize an alternative translocator.
However, cells defective in their TAP1 and TAP2 proteins,
normally responsible for transporting peptides across the
ER membrane for presentation by the MHC class I molecules,
remain completely sensitive to ricin, indicating that the A-
chain does not use the peptide translocator in the reverse
direction [1,4].
Both hydrophobic and hydrophilic amino acids take part in
the contact between the A- and B-subunits of ML [17]. These
are mainly the C-terminal residues not exposed in the holo-
toxin. The important role of these residues in ricin transloca-
tion was shown in cytotoxicity experiments with recombinant
ricin A-chain containing Ala instead of Pro-250. This substi-
tution dramatically decreased the cytotoxic activity of re-as-
sociated holotoxin [18]. Comparative amino acid analysis of
ricin and ML shows that MLA has residues with a high hy-
drophobic index in the interchain region. The main antigenic
epitopes of ML include these residues, as shown by our anal-
ysis.
The comparison of the amino acid sequences of ricin and
ML with other RIP II toxins, namely nigrin b and ebulin
[19,20], which have low cytotoxic activity, shows pronounced
di¡erences between the C-ends of their A-chains. No similar
region is also found in gelonin, a representative of type I RIP.
Receptor-mediated conjugates of gelonin have less cytotoxic
activity than ricin or ML A-chain immunotoxins [21]. Thus,
our study of ML activity on MNA5 hybridoma cells revealed
that the disul¢de bond is reduced and that the chains disso-
ciate before the MLA is translocated into the cytosol. The
intramolecular domain of MLA exposed upon subunit disso-
ciation plays a crucial role in transmembrane penetration.
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